Comprehensive Management of Hypertrophic Cardiomyopathy Beyond Medical Therapy скачать в хорошем качестве

Comprehensive Management of Hypertrophic Cardiomyopathy Beyond Medical Therapy

Hypertrophic Cardiomyopathy (HCM) is a genetic disorder that affects approximately 1 in 500 people. Some individuals with HCM don’t experience symptoms, while others can present with exertional dyspnea, fatigue, palpitations, lightheadedness, syncope, atypical chest pain, cardiac arrhythmias, or sudden cardiac death (SCD) related to ventricular diastolic dysfunction. In this CardioBites, we explore the key aspects of non-pharmacologic management, including identifying SCD risks, atrial fibrillation, family screening, and exercise. Specifically, we look at evaluating personal and family history of SCD, as well as red flags like unexplained fainting, severe left ventricular hypertrophy, apical aneurysm, reduced left ventricular ejection fraction, and other important risk factors. Please visit our post-module evaluation survey as well! Link to survey: https://www.surveymonkey.com/r/8RL5D9K Visit our website: https://hfsa.org/cardiobites HFSA LinkedIn: / hfsa HFSA Twitter: / hfsa HFSA Learning Center: https://learningcenter.hfsa.org/ Join HFSA to enjoy member benefits: https://hfsa.org/membership/membershi...